Temporal and geographic variation in the systemic treatment of advanced prostate cancer

Temporal and geographic variation in the systemic treatment of advanced prostate cancer

Abstract Background Several systemic treatments have been shown to increase survival for patients with metastatic castration-resistant prostate cancer. This study sought to characterize variation in use of the six “focus drugs” (docetaxel, abiraterone, enzalutamide, sipuleucel-T, radium-223, and cab...

Full description

Bibliographic Details
Main Authors: Megan E. V. Caram, Jason P. Estes, Jennifer J. Griggs, Paul Lin, Bhramar Mukherjee
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Cancer
Subjects:
Prostate cancer
Novel agents
Variation
Care delivery
Claims data
Online Access:http://link.springer.com/article/10.1186/s12885-018-4166-3

Internet

http://link.springer.com/article/10.1186/s12885-018-4166-3

Similar Items